Open access
Sep 2026
Development of GuaB Inhibitors to Treat Mycobacterium tuberculosis Infection
Mycobacterium tuberculosis (Mtb) is responsible for more deaths per year than any other infectious disease. Resistance of circulating Mtb to the standard of care treatment regimen is an urgent global health crisis for which novel antibiotic treatments are needed. We have developed extremely potent, orally bioavailabl...
Eric M. Kofoed, Terry D. Crawford, Christine M. Bowman et al.
· ACS Infectious Diseases · 0 citations